MedTrace Logo

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes

NCT07039357 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-27

No results posted yet for this study

Summary

A single-site, open label, confirmatory study assessing two biomarkers indicative of levels of glycaemia; glycated keratin in fingernails and glycated haemoglobin (HbA1c). Screening for diabetes

Conditions

Interventions

DEVICE

Near-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nail

both interventions will be applied in both participant groups

Sponsors & Collaborators

  • Queen Mary University of London

    collaborator OTHER

  • Glyconics Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-28
Primary Completion
2026-04-30
Completion
2026-05-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07039357 on ClinicalTrials.gov